CMS certification 160058
University of Iowa Hospital & Clinics
200 Hawkins Drive, Iowa City, IA 52242
University of Iowa Hospital & Clinics has a CMS overall rating of 2 out of 5 stars. 74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 4. Emergency patients spend a median of 3 h 30 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 3,539 completed surveys, 28% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | IA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 372 visits sampled · US median for EDs of the same volume: 3 h 22 min | 3 h 30 min | 2 h 3 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 28 visits sampled | 4 h 10 min | 3 h 37 min | 4 h 17 min |
| Left before being seen Lower is better · 52,831 patients | 3% | 3% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 86 patients | 48% | 63% | 65% |
How University of Iowa Hospital & Clinics compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| University of Iowa Hospital & ClinicsThis hospital | 2/5 | 74% | 3 h 30 min | 5 better 4 worse |
| University of Iowa Health Care Medical Center DownSame city | 4/5 | 69% | 2 h 29 min | 2 better 3 worse |
| Iowa City VA Medical CenterSame city | 5/5 | 80% | — | 2 better |
| Jones Regional Medical CenterSame ZIP area · Anamosa | 4/5 | 82% | 1 h 56 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Iowa City.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,690 cases | Too few cases | 3% | 3.9% |
| Heart attack 176 cases | Too few cases | 13.7% | 11.9% |
| Heart failure 410 cases | Too few cases | 12.2% | 11.1% |
| Pneumonia 254 cases | Too few cases | 17.3% | 15.2% |
| Stroke 671 cases | Too few cases | 10.7% | 11.9% |
| COPD 117 cases | Too few cases | 12.9% | 8.6% |
| Heart bypass surgery (CABG) 138 cases | Too few cases | 2.2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Worse | 1.25 likely 1.08 – 1.43 | 1 |
| After hip or knee replacement 62 cases | Too few cases | 5% | 4.1% |
| Deaths after a serious but treatable surgical complication 337 cases | Worse | 218.47 per 1,000 likely 186.7 per 1,000 – 250.24 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 11,406 cases | Worse | 1.71 per 1,000 likely 1.33 per 1,000 – 2.09 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 12,436 cases | No different | 0.16 per 1,000 likely 0 per 1,000 – 0.33 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 13,026 cases | No different | 0.32 per 1,000 likely 0.15 per 1,000 – 0.49 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 4,775 cases | No different | 2.75 per 1,000 likely 1.76 per 1,000 – 3.75 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 2,980 cases | No different | 1.8 per 1,000 likely 0.77 per 1,000 – 2.84 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 2,790 cases | No different | 7.99 per 1,000 likely 4.8 per 1,000 – 11.17 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 5,327 cases | No different | 3.57 per 1,000 likely 2.32 per 1,000 – 4.82 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 2,938 cases | No different | 3.96 per 1,000 likely 1.97 per 1,000 – 5.95 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,451 cases | No different | 1.4 per 1,000 likely 0.24 per 1,000 – 2.55 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,685 cases | No different | 1.42 per 1,000 likely 0.74 per 1,000 – 2.09 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.85 likely 0.59 – 1.18 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.42 likely 0.23 – 0.71 | 1 |
| Surgical site infections after colon surgery | No different | 0.71 likely 0.33 – 1.35 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.7 likely 0.18 – 1.9 | 1 |
| MRSA bloodstream infections | No different | 0.73 likely 0.45 – 1.13 | 1 |
| C. diff intestinal infections | Better | 0.41 likely 0.3 – 0.54 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 265 cases | Too few cases | 14.5% | 14.4% |
| Readmitted after heart failure 548 cases | Too few cases | 20.8% | 21.3% |
| Readmitted after pneumonia 281 cases | Too few cases | 16.6% | 17.3% |
| Readmitted after COPD 175 cases | Too few cases | 20.2% | 20% |
| Readmitted after heart bypass surgery 119 cases | Too few cases | 9.7% | 11% |
| Readmitted after hip or knee replacement 68 cases | Too few cases | 5.1% | 5.8% |
| Days back in hospital after a heart attack 239 cases | Too few cases | 14.9 days per 100 | — |
| Days back in hospital after heart failure 483 cases | Too few cases | 5.5 days per 100 | — |
| Days back in hospital after pneumonia 272 cases | Too few cases | 21.3 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 2,801 cases | No different | 13.4 per 1,000 likely 10.6 per 1,000 – 16.8 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 1,465 cases | No different | 10.4 per 100 likely 8.9 per 100 – 12.1 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 1,465 cases | Worse | 7.4 per 100 likely 6.2 per 100 – 8.8 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 2,256 cases | Better | 0.8 likely 0.7 – 1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
4,353 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 157 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pharmacist | 283 |
| Anesthesiology | 252 |
| Internal Medicine | 200 |
| Physician Assistant | 172 |
| Pediatrics | 169 |
| Nurse Practitioner | 168 |
| Diagnostic Radiology | 133 |
| Nurse Anesthetist, Certified Registered | 130 |
| Psychiatry | 127 |
| Emergency Medicine | 111 |
| Surgery | 106 |
| Family Medicine | 93 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $16.1M
- 2020 $18.1M
- 2021 $20.5M
- 2022 $19.6M
- 2023 $23.2M
- 2024 $32.7M
- 2025 $19.9M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $677,931 | 43 |
| Speaking, teaching and other services | $459,113 | 64 |
| Space rental and facility fees | $433,865 | 278 |
| Consulting fees | $236,165 | 7 |
| Medical devices and supplies on long-term loan | $142,964 | 44 |
| Education | $28,286 | 10 |
| Debt forgiveness | $23,077 | 13 |
| Royalties and licensing fees | $9,000 | 1 |
| Gifts | $7,310 | 5 |
| Charitable contributions | $3,500 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $2M | 51 |
| Janssen Research & Development, LLC | $1.6M | 98 |
| Regeneron Pharmaceuticals, Inc. | $1.2M | 104 |
| Pfizer INC. | $1.2M | 102 |
| Amgen Inc. | $894,522 | 8 |
| E.R. Squibb & Sons, L.L.C. | $855,085 | 37 |
| Genentech, Inc. | $643,702 | 66 |
| Takeda Pharmaceuticals U.S.A., Inc. | $635,493 | 126 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE 1/2 STUDY OF REGN7075 (EGFRXCD28 COSTIMULATORY BISPECIFIC ANTIBODY) IN COMBINATION WITH CEMIPLIMAB IN PATIENTS WITH ADVANCED SOLID TUMORS Regeneron Pharmaceuticals, Inc. · NCT04626635 | $638,670 |
| A Phase 1b, Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Sotorasib Monotherapy and in Combination With Other Anti-… Amgen Inc. | $553,019 |
| Imaging Study GE HEALTHCARE | $450,000 |
| A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Autoleucel (Cilta-cel), Talquetamab SC in Co… Janssen Research & Development, LLC | $419,842 |
| Multicenter, randomised, double-blind, placebo-controlled, 48 week, Phase III trial to evaluate the efficacy and safety of survodutide administered s… Boehringer Ingelheim International GmbH | $388,780 |
| Residual Hearing using MED?EL Cochlear Implants study MED-EL Corporation | $357,262 |
| A Phase 1b Multicenter, Open-label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants with Relapsed… Janssen Research & Development, LLC | $353,911 |
| Phase 1b/3 Global, Randomized, Controlled, Open-label Trial Comparing Treatment With RYZ101 to Standard of Care Therapy in Subjects With Inoperable, … E.R. Squibb & Sons, L.L.C. · NCT05477576 | $326,641 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about University of Iowa Hospital & Clinics
Is University of Iowa Hospital & Clinics a good hospital?
University of Iowa Hospital & Clinics has a CMS overall rating of 2 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 4. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend University of Iowa Hospital & Clinics?
74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 3,539 completed HCAHPS surveys.
How long is the wait in the University of Iowa Hospital & Clinics emergency room?
Emergency patients spend a median of 3 h 30 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does University of Iowa Hospital & Clinics receive money from drug and device companies?
Drug and device makers reported $19.9M in payments to University of Iowa Hospital & Clinics for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.